Ebola vaccine not before late 2016 – researcher

2014-10-17 16:20

London – An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the “primary answer” to the current outbreak, a company researcher said.

“We have to be able to manufacture the vaccine at doses that would be consistent with general use and that’s going to take well into 2016,” Doctor Ripley Ballou, head of GSK’s Ebola vaccine research unit, told BBC radio in an interview aired today.

“I don’t think this vaccine should be seen as the primary answer to this particular outbreak but we certainly hope that this vaccine could be used to prevent future outbreaks.

“Unfortunately it’s not going to be as quickly as we would like,” he said, adding: “In retrospect we should have pulled the trigger earlier.”

Ballou said data on the vaccine’s efficacy and safety would not be available before the end of 2015.

“In order for the vaccine to be used we have to have data on its safety and its efficacy and that data will not be available before the end of 2015,” he said.

He added that the whole process was “incredibly accelerated” because vaccine development would normally take seven to 10 years.

GSK’s is one of two vaccines, along with one by United States group NewLink Genetics, that the World Health Organisation has been focusing on and it has helped accelerate clinical trials.

Some clinical trials of the GSK vaccine have begun in the United States and Britain and the WHO has said that about 10 000 doses of the vaccine should be available by early 2015.

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.